An antimetabolite for selected previously treated leukemia or lymphoma.
Profile scope: Nelarabine injection. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Digestive symptoms, mouth soreness, headache, dizziness, mood changes, body discomfort, or swelling may occur.
Serious risks and warning signs
Severe neurological damage can persist after stopping. New weakness, abnormal sensation, walking difficulty, excessive sleepiness, or seizures needs immediate assessment. Infection, bleeding, and dehydration symptoms also require attention. Prior brain or spine treatment affects risk.
A question for your healthcare team
What neurological checks and immediate reporting plan apply during treatment and after the course ends?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.